Screener
Aurinia Pharmaceuticals AUPH Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Aurinia Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
FAQ
- What is Aurinia Pharmaceuticals's current ratio?
- Aurinia Pharmaceuticals (AUPH) reported current ratio of 5.4× in Q2 2026.
- How has Aurinia Pharmaceuticals's current ratio changed year-over-year?
- Aurinia Pharmaceuticals's current ratio increased by 3.7% year-over-year, from 5.2× to 5.4×.
- What is the long-term trend for Aurinia Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's current ratio has grown at a -16.7% compound annual growth rate (CAGR), from 13.1× to 5.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Aurinia Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude